Safety of Drug Therapies Used for Weight Loss and Treatment of Obesity

ISSN： 0114-5916

Source： Drug Safety, Vol.29, Iss.4, 2006-01, pp. : 277-302

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Drug Treatment of Obesity: Established and Emerging Therapies

Mini Reviews in Medicinal Chemistry, Vol. 9, Iss. 6, 2009-06 ,pp. : 664-673

Bentham Science Publishers

Access to resources Recommend Favorite

Pharmacotherapy and Weight-Loss Supplements for Treatment of Paediatric Obesity

By Rogovik Alexander L. Chanoine Jean-Pierre Goldman Ran D.

Drugs, Vol. 70, Iss. 3, 2010-02 ,pp. : 335-346

Adis International

Access to resources Recommend Favorite

Drug safety evaluation of naltrexone/bupropion for the treatment of obesity

By Verpeut Jessica L Bello Nicholas T

Expert Opinion on Drug Safety, Vol. 13, Iss. 6, 2014-06 ,pp. : 831-841

Informa Healthcare

Access to resources Recommend Favorite

Pramlintide promotes weight loss in obesity

Inpharma, Vol. 1, Iss. 1605, 2007-01 ,pp. : 15-15

Adis International

Access to resources Recommend Favorite

Zonisamide enhances weight loss in patients with obesity

Inpharma, Vol. 1, Iss. 1383-1384, 2003-01 ,pp. : 9-9

Adis International

Access to resources Recommend Favorite